Ocrelizumab: a step forward in the evolution of B-cell therapy
Fariha Kausar(Eastern Association for the Surgery of Trauma), Nadera Sweiss(University of Illinois Chicago), Khaldoon Alawneh(Jordan University of Science and Technology), Maria Badaracco(University of Chicago), Ghaleb Sweis(University of Jordan), Timothy B. Niewold(Hospital for Special Surgery), Rafah Salloum(University of Chicago), Ray Sawaqed(Methodist Hospital), Khader N. Mustafa(University of Jordan)
Cited by 64
Related Papers
The WASOG Sarcoidosis Organ Assessment Instrument: An update of a previous clinical tool.
|PubMed|2014|505
Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial
|Annals of the Rheumatic Diseases|2010|503
Association of a functional variant downstream of TNFAIP3 with systemic lupus erythematosus
|Nature Genetics|2011|284
Evaluation of the TREX1 gene in a large multi-ancestral lupus cohort
|Genes and Immunity|2011|281
Racial Difference in Sarcoidosis Mortality in the United States
|CHEST Journal|2014|251